Retraction Note: First-line thalidomide–dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma

Retraction Note: First-line thalidomide–dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma

This paper reported in part on a study of optimal timing of second transplantation in patients with multiple myeloma (http://clinicaltrials.gov/show/NCT00207805). It is being retracted with the consent of all the authors.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2009-06, Vol.43 (11), p.893-893
Hauptverfasser: Abdelkefi, A, Torjman, L, Ben Romdhane, N, Ladeb, S, Omri, H El, Ben Othman, T, Elloumi, M, Bellaj, H, Lakhal, A, Jeddi, R, Aissaouï, L, Saad, A, Hsaïri, M, Boukef, K, Dellagi, K, Ben Abdeladhim, A
Format: Artikel
Sprache:eng
Schlagworte:
Cell Biology
Hematology
Internal Medicine
Medicine
Medicine & Public Health
Public Health
retraction
Retraction Note
Stem Cells
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This paper reported in part on a study of optimal timing of second transplantation in patients with multiple myeloma (http://clinicaltrials.gov/show/NCT00207805). It is being retracted with the consent of all the authors.
ISSN:0268-3369
1476-5365
DOI:10.1038/bmt.2009.113